Sign Up Today and Learn More About American Gene Technologies International Stock
Invest in or calculate the value of your shares in American Gene Technologies International or other pre-IPO companies through EquityZen's platform.
American Gene Technologies International Stock (AGTI)
American Gene Technologies develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders.
About American Gene Technologies International Stock
Founded
2007
Headquarters
Rockville, MD, US
Industries
Software, Artificial Intelligence, Data and Analytics
American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. It develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders. The company's mission is to leverage the power of gene and cell therapy to reduce human suffering from serious human diseases. American Gene Technologies was established in 2007 and is headquartered in Rockville, Maryland.
American Gene Technologies International Press Mentions
Stay in the know about the latest news on American Gene Technologies International
10X Capital Venture Acquisition Corp. Iii- Co,Unit, American Gene Technologies International Inc Entered Into Mutual Termination Of Merger Agreement
tradingview • Jun 23, 2024
10X Capital Venture Acquisition Corp. III Announces Transfer ...
finance • Jan 27, 2024
Addimmune Goes Public in Bid to Cure HIV
lawstreetmedia • Jan 27, 2024
Phenylketonuria Market to Hit US$ 1,230.05 Million By 2030
globenewswire • Jan 27, 2024
Why Focus on Treating Diseases Instead of Curing Them?
lifescivoice • May 25, 2022
American Gene Technologies International Management
Leadership team at American Gene Technologies International
CEO & Founder
Jeffrey A. Galvin
Join now and verify your accreditation status to gain access to:
- American Gene Technologies International current valuation
- American Gene Technologies International stock price
- Available deals in American Gene Technologies International and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading American Gene Technologies International Stock
How to invest in American Gene Technologies International stock?
Accredited investors can buy pre-IPO stock in companies like American Gene Technologies International through EquityZen funds. These investments are made available by existing American Gene Technologies International shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell American Gene Technologies International stock?
Shareholders can sell their American Gene Technologies International stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
